Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Doctors and the DEA Free full text
Top Ten Searches
epidural double lumen lidoderm scopolamine phenylepherene sciatica est pain control pregnancy intubationYour Article Summary
Targeting cancer cells by using an antireceptor antibody-photosensitizer fusion protein
Proceedings of the National Academy of Sciences of the United States of America, 06/10/09
Serebrovskaya EO et al. - Antibody-photosensitizer chemical conjugates are used successfully to kill cancer cells in photodynamic therapy. 4D5scFv-KillerRed showed fine targeting properties and efficiently killed p185HER-2-ECD-expressing cancer cells upon light irradiation. It also showed a remarkable additive effect with the commonly used antitumor agent cisplatin, further demonstrating the potential of the approach.
Today in Adverse Effects/Events...keeping you current
Receive free subspecialty "5-minute updates" via email
Surgery in the Patient with Endocrine Dysfunction
Anesthesiology Clinics, 12/02/09
Obesity, Metabolic Syndrome, and the Surgical Patient
Anesthesiology Clinics, 12/02/09
Innate immunity, coagulation and placenta-related adverse pregnancy outcomes
Thrombosis Research, 11/30/09
Article Search
Sponsor


See Latest Articles


